| Literature DB >> 27382490 |
Tine Verreet1, Mieke Verslegers1, Roel Quintens1, Sarah Baatout1, Mohammed A Benotmane1.
Abstract
Ionizing radiation is omnipresent. We are continuously exposed to natural (e.g., radon and cosmic) and man-made radiation sources, including those from industry but especially from the medical sector. The increasing use of medical radiation modalities, in particular those employing low-dose radiation such as CT scans, raises concerns regarding the effects of cumulative exposure doses and the inappropriate utilization of these imaging techniques. One of the major goals in the radioprotection field is to better understand the potential health risk posed to the unborn child after radiation exposure to the pregnant mother, of which the first convincing evidence came from epidemiological studies on in utero exposed atomic bomb survivors. In the following years, animal models have proven to be an essential tool to further characterize brain developmental defects and consequent functional deficits. However, the identification of a possible dose threshold is far from complete and a sound link between early defects and persistent anomalies has not yet been established. This review provides an overview of the current knowledge on brain developmental and persistent defects resulting from in utero radiation exposure and addresses the many questions that still remain to be answered.Entities:
Mesh:
Year: 2016 PMID: 27382490 PMCID: PMC4921147 DOI: 10.1155/2016/1243527
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Figure 1Milestones of human and mouse neocortical development, with indication of the most radiosensitive period. Modified from [9].
Figure 2Overview of current knowledge regarding early low- and moderate-to-high-dose prenatal irradiation-induced events. 53BP1: P53 binding protein 1, CP: cortical plate, DSB: double-strand break, Gy: Gray, IZ: intermediate zone, RG: radial glial cell, SVZ: subventricular zone, and VZ: ventricular zone.
DNA damage, repair mechanisms, and cell death in the irradiated prenatal neocortex of rodents.
| Stage | Time after irradiation | Dose | Effect | References |
|---|---|---|---|---|
|
| ||||
|
| ||||
| E13.5 | 1 h | 0.01–0.1 Gy | Dose-dependent DNA damage | [ |
| 6 h | 0.1 Gy | Strong reduction in DNA damage foci, not observed at lower doses (0.01–0.05 Gy) | [ | |
|
| ||||
| E14.5 | 1 h | 0.1–0.5 Gy | Dose-dependent and widespread DNA damage, average of 2-3 foci/cell | [ |
| NHEJ in VZ/SVZ | [ | |||
| 2.0 Gy | Widespread DNA damage | [ | ||
| 4 h | 2.0 Gy | G2/M checkpoint release/restart of mitosis | [ | |
| 6 h | 0.5 Gy | G2/M checkpoint release with 67% of mitotic cells having remaining DSB foci | [ | |
| 24 h | 2.0 Gy | Full DNA damage repair, which occurred slower in VZ/SVZ progenitors | [ | |
|
| ||||
|
| ||||
|
| ||||
| E11 | 24 h | 1.0 Gy | Apoptosis mainly restricted to CP | [ |
|
| ||||
| E12.5 | 4 h | 14 Gy | Widespread apoptosis, ATM-independent | [ |
|
| ||||
| E12–E13 | 6 h | 1.0 Gy | 50% decrease in viable cells, caspase-9 dependent | [ |
|
| ||||
| E13-E13.5 | 6 h | 0.01–0.2 Gy | Increased apoptosis mainly restricted to VZ/SVZ | [ |
| 1.5–3 Gy | Dose-dependent, widespread apoptosis | [ | ||
|
| ||||
| E14.5 | 4–8 h | 1.0–2.0 Gy | Dose-dependent increase in apoptosis, gradual from VZ (high) to IZ (low) | [ |
| 3-4 h | 2.0 Gy | High radiosensitivity of G2/M phase cells, p21-independent | [ | |
| 6 h | 0.05–0.1 Gy | Moderate apoptosis mainly in VZ/SVZ | [ | |
| 0.5 Gy | >1% apoptosis, mainly in VZ/SVZ | [ | ||
| 14 h | ≥0.1 Gy | Reduced apoptosis in VZ/SVZ | [ | |
| 24 h | 2.0 Gy | Peak of apoptosis still in VZ/SVZ, but increased apoptosis in CP | [ | |
| Peak of apoptosis in the IZ | [ | |||
|
| ||||
| E15-E15.5 | 3 h | 0.5 Gy | 60% apoptosis in SVZ, 25% in IZ + CP | [ |
| 4 h | 14 Gy | Widespread apoptosis, ATM dependency only in SVZ | [ | |
| 24 h | 0.5 Gy | Gradual increase in upper layer apoptosis; 70% apoptosis in IZ + CP | [ | |
|
| ||||
| E17 | 4 h + 24 h | 0.1–0.2 Gy | Apoptosis in VZ/SVZ + IZ, no difference in PI time points | [ |
| 0.4 Gy | Apoptosis in VZ/SVZ + IZ + CP, no difference in PI time points | [ | ||
E = embryonic stage, Gy = gray, NHEJ = nonhomologous end-joining, HR = homologous recombination, DSB = double-strand break, VZ = ventricular zone, SVZ = subventricular zone, IZ = intermediate zone, CP = cortical plate, ATM = ataxia telangiectasia mutated, and INM = interkinetic nuclear migration.
Societal relevant radiation doses.
| Type of irradiation | Dose (mSv) |
|---|---|
| One return flight New York-London | 0.10 |
| Typical dose of one year on the ISS | 170 |
| Mammography | 3 |
| Radiography: chest | 0.10 |
| Radiography: abdomen | 1.2 |
| CT: head | 2.0 |
| CT: abdomen | 6–10 |
| CT: pelvis | 8–10 |
| Radiotherapy (fractionated) | 40.000–70.000 |
|
| |
| Mean fetal dose (mGy) | |
|
| |
| Radiography: chest | <0.01 |
| Radiography: abdomen | 1.4 |
| CT: head | <0.005 |
| CT: abdomen | 8 |
| CT: pelvis | 25 |
| Breast cancer radiotherapy (50 Gy to the mother) | 50–150 |
Doses are whole-body doses, except for those of medical exposure, which are delivered to a specific organ or the embryo/fetus. CT: computed tomography, Gy: gray, ISS: international space station, Sv: sievert. Based on [167, 170–176].